Is the emergence of inflammatory bowel disease a prime example of "the third epidemiological transition"?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Significance of Epidemiological Background in Preventing the Misdiagnosis of Intestinal Tuberculosis as Crohn's Disease.Internal medicine (Tokyo, Japan) · 2024
   Article
2. Inflammatory Bowel Disease and X (Formerly Twitter) Influencers: Who Are They and What Do They Say?Cureus · 2023
   Article
3. Role of Diet-Microbiome Interaction in Gastrointestinal Disorders and Strategies to Modulate Them with Microbiome-Targeted Therapies.Annual review of nutrition · 2023
   Review
4. Development and Validation of a Smartphone Application for Telenutrition in Patients with Inflammatory Bowel Disease.Diagnostics (Basel, Switzerland) · 2022
   Article
5. Does the road to primary prevention of inflammatory bowel disease start from childhood?JGH open : an open access journal of gastroenterology and hepatology · 2022
   Article
6. Inflammatory bowel diseases in Tamil Nadu: A survey of demographics, clinical profile, and practices.JGH open : an open access journal of gastroenterology and hepatology · 2021
   Article
7. The four epidemiological stages in the global evolution of inflammatory bowel disease.Nature reviews. Gastroenterology & hepatology · 2021
   Review
8. Identification of demographic and environmental factors predisposing to ulcerative colitis in southern India.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2020
   Article
9. Effectiveness and safety of adalimumab biosimilar in inflammatory bowel disease: A multicenter study.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2019
   Article
10. Differentiating Crohn's disease from intestinal tuberculosis.World journal of gastroenterology · 2019
    Review

Corrections and comments

• Comment on
  Risk factors for inflammatory bowel disease: A prospective multi-center study.2018

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as